To date, real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) in respiratory
samples is the current gold standard method for the diagnosis of COVID‐19. 4, 5 However, …

Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …

We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing
in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 − when the first …

Neutralizing antibodies that target the receptor-binding domain (RBD) of the SARS-CoV-2
spike protein are among the most promising approaches against COVID-19 1 , 2 . A bispecific …

The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …

Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a variant of …

Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …

Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …

Letermovir (LMV) inhibits HCMV replication by binding to components of the HCMV‐terminase
complex showing a potential role in prevention of HCMV‐related complications in …

Objectives SARS-CoV-2 T-cell response characterization represents a crucial issue for defining
the role of immune protection against COVID-19. The aim of the study was to assess the …